This inventor holds 2 USPTO granted patents. Top assignees: Hightech Receptor Ab, Sumitomo Chemical Company, Limited, Sumitomo Pharmaceuticals Company Limited. Active years: 1993-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 4 
1 out of 6,964 
1 out of 174 Years Active: 1993-1994
Title: Innovations of Tatsunobu Hozumi
Introduction
Tatsunobu Hozumi is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of proteins that interact with immunoglobulins.
Latest Patents
Hozumi holds 2 patents related to his research. His latest patents include a gene encoding a novel protein H capable of binding to IgG. This gene, isolated from Streptococcus sp. AP1, was expressed in host cells, specifically E. coli, to produce the Protein H. This protein is designed to bind specifically to human IgG of all subclasses, showcasing its potential applications in therapeutic and diagnostic fields.
Career Highlights
Throughout his career, Hozumi has worked with several prominent companies, including Hightech Receptor Ab and Sumitomo Chemical Company, Limited. His work has been instrumental in advancing the understanding of protein interactions and their applications in medicine.
Collaborations
Hozumi has collaborated with notable colleagues such as Hideyuki Gomi and Shizuo Hattori. Their combined expertise has contributed to the success of various projects in the field of biotechnology.
Conclusion
Tatsunobu Hozumi's innovative work in protein research and his contributions to biotechnology highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing scientific knowledge and applications in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile